Insights into oxidative stress and potential novel therapeutic targets for Alzheimer disease

Restorative Neurology and Neuroscience

Volumn 22, Issue 2, 2004, Pages 87-104

  Maiese, Kenneth ^a   Chong, Zhao Zhong ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

amyloid; catenin; Amyloid precursor protein; Cell cycle; Glycogen synthase kinase; Metabotropic glutamate receptor; Mitochondria; Phosphatidylserine; Presenilin

Indexed keywords

ALPHA SECRETASE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANTISENSE OLIGONUCLEOTIDE; BETA SECRETASE; CYCLOSPORIN A; CYTOKINE; DNA; ERYTHROPOIETIN; GAMMA SECRETASE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; GLYCOGEN SYNTHASE KINASE 3BETA; GROWTH FACTOR; LITHIUM; NICOTINAMIDE; NITRIC OXIDE; PHOSPHATIDYLSERINE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; APOPTOSIS; CELL CYCLE; CELL DAMAGE; CELL PROTECTION; CELL SURVIVAL; CYTOKINE PRODUCTION; DNA DEGRADATION; ENZYME ACTIVITY; HUMAN; INFLAMMATION; MEMBRANE PERMEABILITY; MICROGLIA; MITOCHONDRIAL MEMBRANE; NERVE CELL; NONHUMAN; OXIDATIVE STRESS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SEQUENCE HOMOLOGY;

ALZHEIMER DISEASE; ANIMALS; HUMANS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS;

EID: 3042819409     PISSN: 09226028     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (193)

1. S. Adams, P. Green, R. Claxton, S. Simcox, M.V. Williams, K. Walsh and C. Leeuwenburgh, Reactive carbonyl formation by oxidative and non-oxidative pathways, Front Biosci 6 (2001), A17-24.
2. A. Alvarez, J.P. Munoz and R.B. Maccioni, A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons, Exp Cell Res 264 (2001), 266-274.
3. G. Alvarez, J.R. Munoz-Montano, J. Satrustegui, J. Avila, E. Bogonez and J. Diaz-Nido, Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration, FEBS Lett 453 (1999), 260-264.
4. M. Ankarcrona and K. Hultenby, Presenilin-1 is located in rat mitochondria, Biochem Biophys Res Commun 295 (2002), 766-770.
5. M. Aoki, T. Nata, R. Morisnita, H. Matsushita, H. Nakagami, K. Yamamoto, K. Yamazaki, M. Nakabayashi, T. Ogihara and Y. Kaneda, Endothelial apoptosis induced by oxidative stress through activation of nf-kappab: antiapoptotic effect of antioxidant agents on endothelial cells, Hypertension 38 (2001), 48-55.
6. A.E. Aplin, J.S. Jacobsen, B.H. Anderton and J.M. Gallo, Effect of increased glycogen synthase kinase-3 activity upon the maturation of the amyloid precursor protein in transfected cells, Neuroreport 8 (1997), 639-643.
7. T. Arendt, M. Holzer, A. Stobe, U. Gartner, H.J. Luth, M.K. Bruckner and U. Ueberham, Activated mitogenic signaling induces a process of dedifferentiation in Alzheimer's disease that eventually results in cell death, Ann N Y Acad Sci 920 (2000), 249-255.
8. S. Arur, U.E. Uche, K. Rezaul, M. Fong, V. Scranton, A.E. Cowan, W. Mohler and D.K. Han, Annexin I is an endogenous ligand that mediates apoptotic cell engulfment, Dev Cell 4 (2003), 587-598.
9. S.O. Bachurin, E.P. Shevtsova, E.G. Kireeva, G.F. Oxenkrug and S.O. Sablin, Mitochondria as a target for neurotoxins and neuroprotective agents, Ann N Y Acad Sci 993 (2003), 334-344; discussion 345-349.
10. A. Bal-Price and G.C. Brown, Nitric-oxide-induced necrosis and apoptosis in PC12 cells mediated by mitochondria, J Neurochem 75 (2000), 1455-1464.
11. J.G. Begley, W. Duan, S. Chan, K. Duff and M.P. Mattson, Altered calcium homeostasis and mitochondrial dysfunction in cortical synaptic compartments of presenilin-1 mutant mice, J Neurochem 72 (1999), 1030-1039.
12. D.A. Bennett, R.S. Wilson, J.A. Schneider, D.A. Evans, L.A. Beckett, N.T. Aggarwal, L.L. Barnes, J.H. Fox and J. Bach, Natural history of mild cognitive impairment in older persons, Neurology 59 (2002), 198-205.
13. W.C. Benzing, J.R. Wujek, E.K. Ward, D. Shaffer, K.H. Ashe, S.G. Younkin and K.R. Brunden, Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice, Neurobiol Aging 20 (1999), 581-589.
14. M.A. Berger, M.C. Defagot, M.J. Villar and M.C. Antonelli, D4 dopamine and metabotropic glutamate receptors in cerebral cortex and striatum in rat brain, Neurochem Res 26 (2001), 345-352.
15. P. Bernardi, Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore by the proton electrochemical gradient. Evidence that the pore can be opened by membrane depolarization, J Biol Chem 267 (1992), 8834-8839.
16. A. Berthele, S. Platzer, D.J. Laurie, S. Weis, B. Sommer, W. Zieglgansberger, B. Conrad and T.R. Tolle, Expression of metabotropic glutamate receptor subtype mRNA (mGluR1-8) in human cerebellum, Neuroreport 10 (1999), 3861-3867.
17. R.V. Bhat, J. Shanley, M.P. Correll, W.E. Fieles, R.A. Keith, C.W. Scott and C.M. Lee, Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration, Proc Natl Acad Sci USA 97 (2000), 11074-11079.
18. G.N. Bijur, P. De Sarno and R.S. Jope, Glycogen synthase kinase-3beta facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium, J Biol Chem 275 (2000), 7583-7590.
19. I. Blumcke, K. Behle, B. Malitschek, R. Kuhn, T. Knopfel, H.K. Wolf and O.D. Wiestler, Immunohistochemical distribution of metabotropic glutamate receptor subtypes mGluR1b, mGluR2/3, mGluR4a and mGluR5 in human hippocampus, Brain Res 736 (1996), 217-226.
20. K.D. Bornemann, K.H. Wiederhold, C. Pauli, F. Ermini, M. Stalder, L. Schnell, B. Sommer, M. Jucker and M. Staufenbiel, Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice, Am J Pathol 158 (2001), 63-73.
21. N. Bresgen, G. Karlhuber, I. Krizbai, H. Bauer, H.C. Bauer and P.M. Eckl, Oxidative stress in cultured cerebral endothelial cells induces chromosomal aberrations, micronuclei, and apoptosis, J Neurosci Res 72 (2003), 327-333.
22. J. Brown, H. Higo, A. McKalip and B. Herman, Human papillomavirus (HPV) 16 E6 sensitizes cells to atractyloside-induced apoptosis: role of p53, ICE-like proteases and the mitochondrial permeability transition, J Cell Biochem 66 (1997), 245-255.
23. A. Burlacu, C. Jinga, A.V. Gafencu and M. Simionescu, Severity of oxidative stress generates different mechanisms of endothelial cell death, Cell Tissue Res 306 (2001), 409-416.
24. J. Busser, D.S. Geldmacher and K. Herrup, Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain, J Neurosci 18 (1998), 2801-2807.
25. D.A. Butterfield, A. Castegna, C.M. Lauderback and J. Drake, Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death, Neurobiol Aging 23 (2002), 655-664.
26. Z. Cai, F. Xiao, J.D. Fratkin and P.G. Rhodes, Protection of neonatal rat brain from hypoxic-ischemic injury by LY379268, a Group II metabotropic glutamate receptor agonist, Neuroreport 10 (1999), 3927-3931.
27. P. Calabresi, D. Centonze, A. Pisani and G. Bernardi, Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: implication for ischemia and Huntington's disease, Exp Neurol 158 (1999), 97-108.
28. C.S. Casley, J.M. Land, M.A. Sharpe, J.B. Clark, M.R. Duchen and L. Canevari, Beta-amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons, Neurobiol Dis 10 (2002), 258-267.
29. S.L. Chan, C. Culmsee, N. Haughey, W. Klapper and M.P. Mattson, Presenilin-1 mutations sensitize neurons to DNA damage-induced death by a mechanism involving perturbed calcium homeostasis and activation of calpains and caspase-12, Neurobiol Dis 11 (2002), 2-19.
30. G.J. Chen, J. Xu, S.A. Lahousse, N.L. Caggiano and S.M. de la Monte, Transient hypoxia causes Alzheimer-type molecular and biochemical abnormalities in cortical neurons: potential strategies for neuroprotection, J Alzheimers Dis 5 (2003), 209-228.
31. J. Choi, C.A. Malakowsky, J.M. Talent, C.C. Conrad, C.A. Carroll, S.T. Weintraub and R.W. Gracy, Anti-apoptotic proteins are oxidized by Abeta25-35 in Alzheimer's fibroblasts, Biochim Biophys Acta 1637 (2003), 135-141.
32. Z.Z. Chong, J.Q. Kang and K. Maiese, Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases, Circulation 106 (2002), 2973-2979.
33. Z.Z. Chong, J.Q. Kang and K. Maiese, Apaf-1, Bcl-xL, Cytochrome c, and Caspase-9 Form the Critical Elements for Cerebral Vascular Protection by Erythropoietin, J Cereb Blood Flow Metab 23 (2003), 320-330.
34. Z.Z. Chong, J.Q. Kang and K. Maiese, Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways, Br J Pharmacol 138 (2003), 1107-1118.
35. Z.Z. Chong, J.Q. Kang and K. Maiese, Metabotropic glutamate receptors promote neuronal and vascular plasticity through novel intracellular pathways, Histol Histopathol 18 (2003), 173-189.
36. Z.Z. Chong, S.-H. Lin, J. Kang and K. Maiese, The tyrosine phosphatase SHP2 modulates MAP kinase p38 and caspase 1 and 3 to foster neuronal survival, Cell Mol Neurobiol 23(4-5) (2003), 561-578.
37. Z.Z. Chong, S.-H. Lin and K. Maiese, The NAD+ precursor nicotinamide governs neuronal survival during oxidative stress through protein kinase B coupled to FOXO3a and mitochondrial membrane potential, J Cereb Blood Flow Metab (2004), in press.
38. Z.Z. Chong, S.H. Lin, J.Q. Kang and K. Maiese, Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8, J Neurosci Res 71 (2003), 659-669.
39. Z.Z. Chong, S.H. Lin and K. Maiese, Nicotinamide Modulates Mitochondrial Membrane Potential and Cysteine Protease Activity during Cerebral Vascular Endothelial Cell Injury, J Vasc Res 39 (2002), 131-147.
40. M. Citron, C. Vigo-Pelfrey, D.B. Teplow, C. Miller, D. Schenk, J. Johnston, B. Winblad, N. Venizelos, L. Lannfelt and D.J. Selkoe, Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation, Proc. Natl Acad Sci USA 91 (1994), 11993-11997.
41. G.J. Colurso, J.E. Nilson and L.G. Vervoort, Quantitative assessment of DNA fragmentation and beta-amyloid deposition in insular cortex and midfrontal gyrus from patients with Alzheimer's disease, Life Sci 73 (2003), 1795-1803.
42. C.K. Combs, J.C. Karlo, S.C. Kao and G.E. Landreth, beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis, J Neurosci 21 (2001), 1179-1188.
43. D.G. Cook, J.C. Sung, T.E. Golde, K.M. Felsenstein, B.S. Wojczyk, R.E. Tanzi, J.Q. Trojanowski, V.M. Lee and R.W. Doms, Expression and analysis of presenilin 1 in a human neuronal system: localization in cell bodies and dendrites, Proc Natl Acad Sci USA 93 (1996), 9223-9228.
44. R.J. Crowder and R.S. Freeman, Glycogen synthase kinase-3 beta activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal, J Biol Chem 275 (2000), 34266-34271.
45. S.M. de la Monte, J. Chiche, A. von dem Bussche, S. Sanyal, S.A. Lahousse, S.P. Janssens and K.D. Bloch, Nitric oxide synthase-3 overexpression causes apoptosis and impairs neuronal mitochondrial function: relevance to Alzheimer's-type neurodegeneration, Lab Invest 83 (2003), 287-298.
46. S.M. de la Monte, B.X. Lu, T.K. Sohn, D. Etienne, J. Kraft, N. Ganju and J.R. Wands, Aberrant expression of nitric oxide synthase III in Alzheimer's disease: relevance to cerebral vasculopathy and neurodegeneration, Neurobiol Aging 21 (2000), 309-319.
47. D. Dewar, D.T. Chalmers, D.I. Graham and J. McCulloch, Glutamate metabotropic and AMPA binding sites are reduced in Alzheimer's disease: an autoradiographic study of the hippocampus, Brain Res 553 (1991), 58-64.
48. A. Doan, G. Thinakaran, D.R. Borchelt, H.H. Slunt, T. Ratovitsky, M. Podlisny, D.J. Selkoe, M. Seeger, S.E. Gandy, D.L. Price and S.S. Sisodia, Protein topology of presenilin 1, Neuron 17 (1996), 1023-1030.
49. D. Dombroski, K. Balasubramanian and A.J. Schroit, Phosphatidylserine expression on cell surfaces promotes antibody- dependent aggregation and thrombosis in beta2-glycoprotein I-immune mice, J Autoimmun 14 (2000), 221-229.
50. S. Dore, S. Kar and R. Quirion, Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity, Proc Natl Acad Sci USA 94 (1997), 4772-4777.
51. B.F. El-Khodor, T. Frances Oo, N. Kholodilov and R.E. Burke, Ectopic expression of cell cycle markers in models of induced programmed cell death in dopamine neurons of the rat substantia nigra pars compacta, Exp Neurol 179 (2003), 17-27.
52. F.S. Esch, P.S. Keim, E.C. Beattie, R.W. Blacher, A.R. Culwell, T. Oltersdorf, D. McClure and P.J. Ward, Cleavage of amyloid beta peptide during constitutive processing of its precursor, Science 248 (1990), 1122-1124.
53. V.A. Fadok, A. de Cathelineau, D.L. Daleke, P.M. Henson and D.L. Bratton, Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts, J Biol Chem 276 (2001), 1071-1077.
54. F. Ferraguti, B. Baldani-Guerra, M. Corsi, S. Nakanishi and C. Corti, Activation of the extracellular signal-regulated kinase 2 by metabotropic glutamate receptors, Eur J Neurosci 11 (1999), 2073-2082.
55. D.B. Flaherty, J.P. Soria, H.G. Tomasiewicz and J.G. Wood, Phosphorylation of human tau protein by microtubule-associated kinases: GSK3beta and cdk5 are key participants, J Neurosci Res 62 (2000), 463-472.
56. A. Francesconi and R.M. Duvoisin, Role of the second and third intracellular loops of metabotropic glutamate receptors in mediating dual signal transduction activation, J Biol Chem 273 (1998), 5615-5624.
57. S.S. Gill, O.M. Pulido, R.W. Mueller and P.F. McGuire, Immunochemical localization of the metabotropic glutamate receptors in the rat heart, Brain Res Bull 48 (1999), 143-146.
58. A. Giovanni, F. Wirtz-Brugger, E. Keramaris, R. Slack and D.S. Park, Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F x DP, in B-amyloid-induced neuronal death, J Biol Chem 274 (1999), 19011-19016.
59. M. Goedert, B. Ghetti and M.G. Spillantini, Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Their relevance for understanding the neurogenerative process, Ann N Y Acad Sci 920 (2000), 74-83.
60. Y. Goldshmit, S. Erlich and R. Pinkas-Kramarski, Neuregulin rescues PC12-ErbB4 cells from cell death induced by H(2)O(2). Regulation of reactive oxygen species levels by phosphatidylinositol 3-kinase, J Biol Chem 276 (2001), 46379-46385.
61. P.A. Gregoli and M.C. Bondurant, The roles of Bcl-X(L) and apopain in the control of erythropoiesis by erythropoietin, Blood 90 (1997), 630-640.
62. Q. Guo, W. Fu, J. Xie, H. Luo, S.F. Sells, J.W. Geddes, V. Bondada, V.M. Rangnekar and M.P. Mattson, Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease, Nat Med 4 (1998), 957-962.
63. T. Hagen, E. Di Daniel, A.A. Culbert and A.D. Reith, Expression and characterization of GSK-3 mutants and their effect on beta-catenin phosphorylation in intact cells, J Biol Chem 277 (2002), 23330-23335.
64. R. Hanayama, M. Tanaka, K. Miwa, A. Shinohara, A. Iwamatsu and S. Nagata, Identification of a factor that links apoptotic cells to phagocytes, Nature 417 (2002), 182-187.
65. Y. Hashimoto, T. Niikura, T. Chiba, E. Tsukamoto, H. Kadowaki, H. Nishitoh, Y. Yamagishi, M. Ishizaka, M. Yamada, M. Nawa, K. Terashita, S. Aiso, H. Ichijo and I. Nishimoto, The cytoplasmic domain of Alzheimer's amyloid-beta protein precursor causes sustained apoptosis signal-regulating kinase 1/c-Jun NH2-terminal kinase-mediated neurotoxic signal via dimerization, J Pharmacol Exp Ther 306 (2003), 889-902.
66. K. Hatori, A. Nagai, R. Heisel, J.K. Ryu and S.U. Kim, Fractalkine and fractarkine receptors in human neurons and glial cells, J Neurosci Res 69 (2002), 418-426.
67. P.R. Hoffmann, A.M. deCathelineau, C.A. Ogden, Y. Leverrier, D.L. Bratton, D.L. Daleke, A.J. Ridley, C.A. Fadok and P.M. Henson, Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells, J Cell Biol 155 (2001), 649-659.
68. M. Hong, D.C. Chen, P.S. Klein and V.M. Lee, Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3, J Biol Chem 272 (1997), 25326-25332.
69. K.M. Houamed, J.L. Kuijper, R.L. Gilbert, B.A. Haldeman, P.J. O'Hara, E.R. Mulvihill, W. Almers and F.S. Hagen, Cloning, expression, and gene structure of a G protein-coupled glutamate receptor from rat brain, Science 252 (1991), 1318-1321.
70. Y. Hu, M.A. Benedict, L. Ding and G. Nunez, Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase- 9 activation and apoptosis, Embo J 18 (1999), 3586-3595.
71. X. Huang, C.S. Atwood, M.A. Hartshorn, G. Multhaup, L.E. Goldstein, R.C. Scarpa, M.P. Cuajungco, D.N. Gray, J. Lim, R.D. Moir, R.E. Tanzi and A.I. Bush, The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction, Biochemistry 38 (1999), 7609-7616.
72. G.W. Hubert, M. Paquet and Y. Smith, Differential subcellular localization of mGluR1a and mGluR5 in the rat and monkey Substantia nigra, J Neurosci 21 (2001), 1838-1847.
73. R. Imberti, A.L. Nieminen, B. Herman and J.J. Lemasters, Mitochondrial and glycolytic dysfunction in lethal injury to hepatocytes by t-butylhydroperoxide: protection by fructose, cyclosporin A and trifluoperazine, J Pharmacol Exp Ther 265 (1993), 392-400.
74. H. Ino and T. Chiba, Cyclin-dependent kinase 4 and cyclin D1 are required for excitotoxin-induced neuronal cell death in vivo, J Neurosci 21 (2001), 6086-6094.
75. R. Jessel, S. Haertel, C. Socaciu, S. Tykhonova and H.A. Diehl, Kinetics of apoptotic markers in exogeneously induced apoptosis of EL4 cells, J Cell Mol Med 6 (2002), 82-92.
76. C. Jolly-Tornetta, Z.Y. Gao, C.M. Lee and B.A. Wolf, Regulation of amyloid precursor protein secretion by glutamate receptors in human Ntera 2 neurons, J Biol Chem 273 (1998), 14015-14021.
77. A. Kalda, A. Kaasik, V. Vassiljev, P. Pokk and A. Zharkovsky, Neuroprotective action of group I metabotropic glutamate receptor agonists against oxygen-glucose deprivation-induced neuronal death, Brain Res 853 (2000), 370-373.
78. J.Q. Kang, Z.Z. Chong and K. Maiese, Akt1 protects against inflammatory microglial activation through maintenance of membrane asymmetry and modulation of cysteine protease activity, J Neurosci Res 74 (2003), 37-51.
79. J.Q. Kang, Z.Z. Chong and K. Maiese, Critical role for akt1 in the modulation of apoptotic phosphatidylserine exposure and microglial activation, Mol Pharmacol 64 (2003), 557-569.
80. H.S. Kim, E.M. Kim, J.P. Lee, C.H. Park, S. Kim, J.H. Seo, K.A. Chang, E. Yu, S.J. Jeong, Y.H. Chong and Y.H. Suh, C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3beta expression, Faseb J 15 (2003), 15.
81. H.S. Kim, J.H. Lee, J.P. Lee, E.M. Kim, K.A. Chang, C.H. Park, S.J. Jeong, M.C. Wittendorp, J.H. Seo, S.H. Choi and Y.H. Suh, Amyloid beta peptide induces cytochrome C release from isolated mitochondria, Neuroreport 13 (2002), 1989-1993.
82. A.E. Kingston, M.J. O'Neill, A. Lam, K.R. Bales, J.A. Monn and D.D. Schoepp, Neuroprotection by metabotropic glutamate receptor glutamate receptor agonists: LY354740, LY379268 and LY389795, Eur J Pharmacol 377 (1999), 155-165.
83. F. Kirschenbaum, S.C. Hsu, B. Cordell and J.V. McCarthy, Substitution of a glycogen synthase kinase-3beta phosphorylation site in presenilin 1 separates presenilin function from beta-catenin signaling, J Biol Chem 276 (2001), 7366-7375.
84. S.H. Koh, S.H. Kim, H. Kwon, Y. Park, K.S. Kim, C.W. Song, J. Kim, M.H. Kim, H.J. Yu, J.S. Henkel and H.K. Jung, Epigallocatechin gallate protects nerve growth factor differentiated PC12 cells from oxidative-radical-stress-induced apoptosis through its effect on phosphoinositide 3-kinase/Akt and glycogen synthase kinase-3, Brain Res Mol Brain Res 118 (2003), 72-81.
85. Y. Konishi and A. Bonni, The E2F-Cdc2 cell-cycle pathway specifically mediates activity deprivation-induced apoptosis of postmitotic neurons, J Neurosci 23 (2003), 1649-1658.
86. Y. Koriyama, K. Chiba and T. Mohri, Propentofylline protects beta-amyloid protein-induced apoptosis in cultured rat hippocampal neurons, Eur J Pharmacol 458 (2003), 235-241.
87. D.M. Kovacs, H.J. Fausett, K.J. Page, T.W. Kim, R.D. Moir, D.E. Merriam, R.D. Hollister, O.G. Hallmark, R. Mancini, K.M. Felsenstein, B.T. Hyman, R.E. Tanzi and W. Wasco, Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells, Nat Med 2 (1996), 224-229.
88. I.A. Krizbai, M.A. Deli, A. Pestenacz, L. Siklos, C.A. Szabo, I. Andras and F. Joo, Expression of glutamate receptors on cultured cerebral endothelial cells, J Neurosci Res 54 (1998), 814-819.
89. K. Lauber, E. Bohn, S.M. Krober, Y.J. Xiao, S.G. Blumenthal, R.K. Lindemann, P. Marini, C. Wiedig, A. Zobywalski, S. Baksh, Y. Xu, I.E. Autenrieth, K. Schulze-Osthoff, C. Belka, G. Stuhler and S. Wesselborg, Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal, Cell 113 (2003), 717-730.
90. D.H. Lee, T.R. O'Connor and G.P. Pfeifer, Oxidative DNA damage induced by copper and hydrogen peroxide promotes CG→TT tandem mutations at methylated CpG dinucleotides in nucleotide excision repair-deficient cells, Nucleic Acids Res 30 (2002), 3566-3573.
91. R.K. Lee, J. Jimenez, A.J. Cox and R.J. Wurtman, Metabotropic glutamate receptors regulate APP processing in hippocampal neurons and cortical astrocytes derived from fetal rats, Ann N Y Acad Sci 777 (1996), 338-343.
92. R.K. Lee, R.J. Wurtman, A.J. Cox and R.M. Nitsch, Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors, Proc Natl Acad Sci USA 92 (1995), 8083-8087.
93. S.V. Lemeshko and V.V. Lemeshko, Metabolically derived potential on the outer membrane of mitochondria: a computational model, Biophys J 79 (2000), 2785-2800.
94. L.Y. Li, X. Luo and X. Wang, Endonuclease G is an apoptotic DNase when released from mitochondria, Nature 412 (2001), 95-99.
95. S. Lin, Z.Z. Chong and K. Maiese, Cell cycle induction in post-mitotic neurons proceeds in concert with the initial phase of programmed cell death in rat, Neurosci Lett 310 (2001), 173-177.
96. S.H. Lin and K. Maiese, Group I metabotropic glutamate receptors prevent endothelial programmed cell death independent from MAP kinase p38 activation in rat, Neurosci Lett 298 (2001), 207-211.
97. S.H. Lin and K. Maiese, The metabotropic glutamate receptor system protects against ischemic free radical programmed cell death in rat brain endothelial cells, J Cereb Blood Flow Metab 21 (2001), 262-275.
98. S.H. Lin, A. Vincent, T. Shaw, K.I. Maynard and K. Maiese, Prevention of nitric oxide-induced neuronal injury through the modulation of independent pathways of programmed cell death, J Cereb Blood Flow Metab 20 (2000), 1380-1391.
99. Y. Liu, G. Fiskum and D. Schubert, Generation of reactive oxygen species by the mitochondrial electron transport chain, J Neurochem 80 (2002), 780-787.
100. M.A. Lovell, S.P. Gabbita and W.R. Markesbery, Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF, J Neurochem 72 (1999), 771-776.
101. J.J. Lucas, F. Hernandez, P. Gomez-Ramos, M.A. Moran, R. Hen and J. Avila, Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice, Embo J 20 (2001), 27-39.
102. E.N. Maciel, A.E. Vercesi and R.F. Castilho, Oxidative stress in Ca(2+)-induced membrane permeability transition in brain mitochondria, J Neurochem 79 (2001), 1237-1245.
103. K. Maiese, The dynamics of cellular injury: transformation into neuronal and vascular protection, Histol Histopathol 16 (2001), 633-644.
104. K. Maiese, I. Ahmad, M. TenBroeke and J. Gallant, Metabotropic glutamate receptor subtypes independently modulate neuronal intracellular calcium, J Neurosci Res 55 (1999), 472-485.
105. K. Maiese and Z.Z. Chong, Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain, Trends Pharmacol Sci 24 (2003), 228-232.
106. K. Maiese, S. Lin and Z.Z. Chong, Elucidating neuronal and vascular injury through the cytoprotective agent nicotinamide, Curr Med Chem-Imm, Endoc. & Metab. Agents 1 (2001), 257-267.
107. K. Maiese, M. Swiriduk and M. TenBroeke, Cellular mechanisms of protection by metabotropic glutamate receptors during anoxia and nitric oxide toxicity, J Neurochem 66 (1996), 2419-2428.
108. K. Maiese, A. Vincent, S.H. Lin and T. Shaw, Group I and Group III metabotropic glutamate receptor subtypes provide enhanced neuroprotection, J Neurosci Res 62 (2000), 257-272.
109. K. Maiese and A.M. Vincent, Membrane asymmetry and DNA degradation: functionally distinct determinants of neuronal programmed cell death, J Neurosci Res 59 (2000), 568-580.
110. A. Makoff, R. Lelchuk, M. Oxer, K. Harrington and P. Emson, Molecular characterization and localization of human metabotropic glutamate receptor type 4, Brain Res Mol Brain Res 37 (1996), 239-248.
111. A. Makoff, F. Volpe, R. Lelchuk, K. Harrington and P. Emson, Molecular characterization and localization of human metabotropic glutamate receptor type 3, Brain Res Mol Brain Res 40 (1996), 55-63.
112. L. Mao and J.Q. Wang, Differentially altered mGluR1 and mGluR5 mRNA expression in rat caudate nucleus and nucleus accumbens in the development and expression of behavioral sensitization to repeated amphetamine administration, Synapse 41 (2001), 230-240.
113. P. Marambaud, P.H. Wen, A. Dutt, J. Shioi, A. Takashima, R. Siman and N.K. Robakis, A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations, Cell 114 (2003), 635-645.
114. M. Masu, Y. Tanabe, K. Tsuchida, R. Shigemoto and S. Nakanishi, Sequence and expression of a metabotropic glutamate receptor, Nature 349 (1991), 760-765.
115. M.P. Mattson, Oxidative stress, perturbed calcium homeostasis, and immune dysfunction in Alzheimer's disease, J Neurovirol 8 (2002), 539-550.
116. D.L. McPhie, R. Coopersmith, A. Hines-Peralta, Y. Chen, K.J. Ivins, S.P. Manly, M.R. Kozlowski, K.A. Neve and R.L. Neve, DNA synthesis and neuronal apoptosis caused by familial Alzheimer disease mutants of the amyloid precursor protein are mediated by the p21 activated kinase PAK3, J Neurosci 23 (2003), 6914-6927.
117. A. McShea, P.L. Harris, K.R. Webster, A.F. Wahl and M.A. Smith, Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease, Am J Pathol 150 (1997), 1933-1939.
118. G. Mehlhorn, M. Hollborn and R. Schliebs, Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology, Int J Dev Neurosci 18 (2000), 423-431.
119. D. Metodiewa and C. Koska, Reactive oxygen species and reactive nitrogen species: relevance to cyto(neuro)toxic events and neurologic disorders, An overview, Neurotox Res 1 (2000), 197-233.
120. B. Michalski and M. Fahnestock, Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease, Brain Res Mol Brain Res 111 (2003), 148-154.
121. A. Monji, H. Utsumi, T. Ueda, T. Imoto, I. Yoshida, S. Hashioka, K. Tashiro and N. Tashiro, The relationship between the aggregational state of the amyloid-beta peptides and free radical generation by the peptides, J Neurochem 77 (2001), 1425-1432.
122. J.R. Munoz-Montano, F.J. Moreno, J. Avila and J. Diaz-Nido, Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons, FEBS Lett 411 (1997), 183-188.
123. T. Nakagawa, H. Zhu, N. Morishima, E. Li, J. Xu, B.A. Yankner and J. Yuan, Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta, Nature 403 (2000), 98-103.
124. I. Nishimura, T. Uetsuki, K. Kuwako, T. Hara, T. Kawakami, S. Aimoto and K. Yoshikawa, Cell death induced by a caspase-cleaved transmembrane fragment of the Alzheimer amyloid precursor protein, Cell Death Differ 9 (2002), 199-208.
125. W. Noble, V. Olm, K. Takata, E. Casey, O. Mary, J. Meyerson, K. Gaynor, J. LaFrancois, L. Wang, T. Kondo, P. Davies, M. Burns, R. Veeranna, Nixon, D. Dickson, Y. Matsuoka, M. Ahlijanian, L.F. Lau and K. Duff, Cdk5 is a key factor in tau aggregation and tangle formation in vivo, Neuron 38 (2003), 555-565.
126. Z.N. Oltvai and S.J. Korsmeyer, Checkpoints of dueling dimers foil death wishes, Cell 79 (1994), 189-192.
127. J. Padmanabhan, D.S. Park, L.A. Greene and M.L. Shelanski, Role of cell cycle regulatory proteins in cerebellar granule neuron apoptosis, J Neurosci 19 (1999), 8747-8756.
128. E. Paradis, H. Douillard, M. Koutroumanis, C. Goodyer and A. LeBlanc, Amyloid beta peptide of Alzheimer's disease downregulates Bcl-2 and upregulates bax expression in human neurons, J Neurosci 16 (1996), 7533-7539.
129. G.N. Patrick, L. Zukerberg, M. Nikolic, S. de la Monte, P. Dikkes and L.H. Tsai, Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration, Nature 402 (1999), 615-622.
130. J.J. Pei, E. Braak, H. Braak, I. Grundke-Iqbal, K. Iqbal, B. Winblad and R.F. Cowburn, Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes, J Neuropathol Exp Neurol 58 (1999), 1010-1019.
131. J.J. Pei, I. Grundke-Iqbal, K. Iqbal, N. Bogdanovic, B. Winblad and R.F. Cowburn, Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration, Brain Res 797 (1998), 267-277.
132. D.E. Pellegrini-Giampietro, F. Peruginelli, E. Meli, A. Cozzi, S. Albani-Torregrossa, R. Pellicciari and F. Moroni, Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: time-course and mechanisms, Neuropharmacology 38 (1999), 1607-1619.
133. J.P. Pin and R. Duvoisin, The metabotropic glutamate receptors: structure and functions, Neuropharmacol 34 (1995), 1-26.
134. L. Prezeau, O. Manzoni, V. Homburger, F. Sladeczek, K. Curry and J. Bockaert, Characterization of a metabotropic glutamate receptor: direct negative coupling to adenylyl cyclase and involvement of a pertussis toxin-sensitive G protein, Proceedings of the National Academy of Sciences of the United States of America 89 (1992), 8040-8044.
135. S. Pugazhenthi, A. Nesterova, P. Jambal, G. Audesirk, M. Kern, L. Cabell, E. Eves, M.R. Rosner, L.M. Boxer and J.E. Reusch, Oxidative stress-mediated down-regulation of bcl-2 promoter in hippocampal neurons, J Neurochem 84 (2003), 982-996.
136. Y. Qi, M. Morishima-Kawashima, T. Sato, R. Mitsumori and Y. Ihara, Distinct mechanisms by mutant presenilin 1 and 2 leading to increased intracellular levels of amyloid beta-protein 42 in Chinese hamster ovary cells, Biochemistry 42 (2003), 1042-1052.
137. A.K. Raina, X. Zhu, C.A. Rottkamp, M. Monteiro, A. Takeda and M.A. Smith, Cyclin' toward dementia: cell cycle abnormalities and abortive oncogenesis in Alzheimer disease, J Neurosci Res 61 (2000), 128-133.
138. J.O. Reilly, I.D. Karavanova, K.P. Williams, N.K. Mahanthappa and K.L. Allendoerfer, Cooperative effects of Sonic Hedgehog and NGF on basal forebrain cholinergic neurons, Mol Cell Neurosci 19 (2002), 88-96.
139. H.J. Rideout, Q. Wang, D.S. Park and L. Stefanis, Cyclin-dependent kinase activity is required for apoptotic death but not inclusion formation in cortical neurons after proteasomal inhibition, J Neurosci 23 (2003), 1237-1245.
140. G. Riedel, T. Opitz and K.G. Reymann, Blockade of metabotropic glutamate receptors protects hippocampal neurons from hypoxia-induced cell death in rat in vivo. Prog Neuropsychopharmacol Biol Psychiatry 20 (1996), 1253-1263.
141. C.M. Rodrigues, S. Sola, R. Silva and D. Brites, Bilirubin and amyloid-beta peptide induce cytochrome c release through mitochondrial membrane permeabilization, Mol Med 6 (2000), 936-946.
142. Y. Sagara and D. Schubert, The activation of metabotropic glutamate receptors protects nerve cells from oxidative stress, J Neurosci 18 (1998), 6662-6671.
143. M. Salinas, R. Diaz, N.G. Abraham, C.M. Ruiz de Galarreta and A. Cuadrado, Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner, J Biol Chem 278 (2003), 13898-13904.
144. S. Sankarapandi, J.L. Zweier, G. Mukherjee, M.T. Quinn and D.L. Huso, Measurement and characterization of superoxide generation in microglial cells: evidence for an NADPH oxidase-dependent pathway, Arch Biochem Biophys 353 (1998), 312-321.
145. J.A. Saugstad, J.M. Kinzie, M.M. Shinohara, T.P. Segerson and G.L. Westbrook, Cloning and expression of rat metabotropic glutamate receptor 8 reveals a distinct pharmacological profile, Mol Pharmacol 51 (1997), 119-125.
146. D.J. Selkoe, Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease, J Clin Invest 110 (2002), 1375-1381.
147. P. Seubert, T. Oltersdorf, M.G. Lee, R. Barbour, C. Blomquist, D.L. Davis, K. Bryant, L.C. Fritz, D. Galasko and L.J. Thal et al., Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide, Nature 361 (1993), 260-263.
148. S.K. Sharma and M. Ebadi, Metallothionein attenuates 3- morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons, Antioxid Redox Signal 5 (2003), 251-264.
149. M. Shaw, P. Cohen and D.R. Alessi, Further evidence that the inhibition of glycogen synthase kinase-3beta by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216, FEBS Lett 416 (1997), 307-311.
150. R. Sherrington, E.I. Rogaev, Y. Liang, E.A. Rogaeva, G. Levesque, M. Ikeda, H. Chi, C. Lin, G. Li and K. Holman et al., Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease, Nature 375 (1995), 754-760.
151. A. Shuaib and R. Kanthan, Amplification of inhibitory mechanisms in cerebral ischemia: an alternative approach to neuronal protection, Histol Histopathol 12 (1997), 185-194.
152. M. Silva, D. Grillot, A. Benito, C. Richard, G. Nunez and J.L. Fernandez-Luna, Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2, Blood 88 (1996), 1576-1582.
153. N. Simpkins and J. Jankovic, Neuroprotection in Parkinson disease, Arch Intern Med 163 (2003), 1650-1654.
154. A.W. Siu and C.H. To, Nitric oxide and hydroxyl radical-induced retinal lipid peroxidation in vitro, Clin Exp Optom 85 (2002), 378-382.
155. J. Smeitink, L. van den Heuvel, W. Koopman, L. Nijtmans, C. Ugalde and P. Willems, Cell Biological Consequences of Mitochondrial NADH: Ubiquinone Oxidoreductase Deficiency, Curr Neurovasc Res 1 (2004), 29-40.
156. W. Paschen, Endoplasmic Reticulum Dysfunction in Brain Pathology: Critical Role of Protein Synthesis, Curr Neurovasc Res 1 (2004), 173-181.
157. I.F. Smith, J.P. Boyle, P.F. Vaughan, H.A. Pearson, R.F. Cowburn and C.S. Peers, Ca(2+) stores and capacitative Ca(2+) entry in human neuroblastoma (SH-SY5Y) cells expressing a familial Alzheimer's disease presenilin-1 mutation, Brain Res 949 (2002), 105-111.
158. M.A. Smith, K. Hirai, K. Hsiao, M.A. Pappolla, P.L. Harris, S.L. Siedlak, M. Tabaton and G. Perry, Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress, J Neurochem 70 (1998), 2212-2215.
159. X. Sun, S. Sato, O. Murayama, M. Murayama, J.M. Park, H. Yamaguchi and A. Takashima, Lithium inhibits amyloid secretion in COS7 cells transfected with amyloid precursor protein C100, Neurosci Lett 321 (2002), 61-54.
160. S.A. Susin, H.K. Lorenzo, N. Zamzami, I. Marzo, B.E. Snow, G.M. Brothers, J. Mangion, E. Jacotot, P. Costantini, M. Loeffler, N. Larochette, D.R. Goodlett, R. Aebersold, D.P. Siderovski, J.M. Penninger and G. Kroemer, Molecular characterization of mitochondrial apoptosis-inducing factor, Nature 397 (1999), 441-446.
161. A. Takashima, T. Honda, K. Yasutake, G. Michel, O. Murayama, M. Murayama, K. Ishiguro and H. Yamaguchi, Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons, Neurosci Res 31 (1998), 317-323.
162. A. Takashima, M. Murayama, O. Murayama, T. Kohno, T. Honda, K. Yasutake, N. Nihonmatsu, M. Mercken, H. Yamaguchi, S. Sugihara and B. Wolozin, Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau, Proc Natl Acad Sci USA 95 (1998), 9637-9641.
163. A. Takashima, K. Noguchi, K. Sato, T. Hoshino and K. Imahori, Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity, Proc Natl Acad Sci USA 90 (1993), 7789-7793.
164. 2 and 4-hydroxynonenal mediate amyloid beta-induced neuronal apoptosis by activating JNKs and p38MAPK, Exp Neurol 180 (2003), 144-155.
165. D.L. Taylor, L.T. Diemel and J.M. Pocock, Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity, J Neurosci 23 (2003), 2150-2160.
166. C.M. Testa, D.G. Standaert, G.B. Landwehrmeyer, J.B. Penney, Jr. and A.B. Young, Differential expression of mGluR5 metabotropic glutamate receptor mRNA by rat striatal neurons, J Comp Neurol 354 (1995), 241-252.
167. S. Timsit, S. Rivera, P. Ouaghi, F. Guischard, E. Tremblay, Y. Ben-Ari and M. Khrestchatisky, Increased cyclin D1 in vulnerable neurons in the hippocampus after ischaemia and epilepsy: a modulator of in vivo programmed cell death? Eur J Neurosci 11 (1999), 263-278.
168. T. Town, J. Zolton, R. Shaffner, B. Schnell, R. Crescentini, Y. Wu, J. Zeng, A. DelleDonne, D. Obregon, J. Tan and M. Mullan, p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro, J Neurosci Res 69 (2002), 362-372.
169. C.M. Troy, S.A. Rabacchi, Z. Xu, A.C. Maroney, T.J. Connors, M.L. Shelanski and L.A. Greene, beta-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation, J Neurochem 77 (2001), 157-164.
170. S. Ueda, H. Masutani, H. Nakamura, T. Tanaka, M. Ueno and J. Yodoi, Redox control of cell death, Antioxid Redox Signal 4 (2002), 405-414.
171. I.H. Ulus and R.J. Wurtman, Metabotropic glutamate receptor agonists increase release of soluble amyloid precursor protein derivatives from rat brain cortical and hippocampal slices, J Pharmacol Exp Ther 281 (1997), 149-154.
172. D. Vaudry, T.F. Pamantung, M. Basille, C. Rousselle, A. Fournier, H. Vaudry, J.C. Beauvillain and B.J. Gonzalez, PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis, Eur J Neurosci 15 (2002), 1451-1460.
173. A.M. Verhagen, P.G. Ekert, M. Pakusch, J. Silke, L.M. Connolly, G.E. Reid, R.L. Moritz, R.J. Simpson and D.L. Vaux, Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins, Cell 102 (2000), 43-53.
174. A.M. Vincent and K. Maiese, Direct temporal analysis of apoptosis induction in living adherent neurons, J Histochem Cytochem 47 (1999), 661-672.
175. A.M. Vincent and K. Maiese, Nitric oxide induction of neuronal endonuclease activity in programmed cell death, Exp Cell Res 246 (1999), 290-300.
176. A.M. Vincent and K. Maiese, The metabotropic glutamate system promotes neuronal survival through distinct pathways of programmed cell death, Exp Neurol 166 (2000), 65-82.
177. A.M. Vincent, Y. Mohammad, I. Ahmad, R. Greenberg and K. Maiese, Metabotropic glutamate receptors prevent nitric oxide induced programmed cell death, J Neurosci Res 50 (1997), 549-564.
178. A.M. Vincent, M. TenBroeke and K. Maiese, Metabotropic glutamate receptors prevent programmed cell death through the modulation of neuronal endonuclease activity and intracellular pH, Exp Neurol 155 (1999), 79-94.
179. 2 and NO on apoptosis involving activation of p38 mitogen-activated protein kinase and caspase-3, J Neurosci Res 72 (2003), 508-519.
180. R. Wang, H.Y. Zhang and X.C. Tang, Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by beta-amyloid protein-(1-40) in rat, Eur J Pharmacol 421 (2001), 149-156.
181. T.C. Wen, Y. Sadamoto, J. Tanaka, P.X. Zhu, K. Nakata, Y.J. Ma, R. Hata and M. Sakanaka, Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by up-regulating Bcl-xL expression, J Neurosci Res 67 (2002), 795-803.
182. A. Witting, P. Muller, A. Herrmann, H. Kettenmann and C. Nolte, Phagocytic clearance of apoptotic neurons by Microglia/Brain macrophages in vitro: involvement of lectin-, integrin-, and phosphatidylserine-mediated recognition, J Neurochem 75 (2000), 1060-1070.
183. X. Xu, Y.C. Shi, W. Gao, G. Hao, G. Zhao, S. Agrawal, G.M. Chisolm, D. Sui and M.Z. Cui, The novel presenilin-1-associated protein is a proapoptotic mitochondrial protein, J Biol Chem 277 (2002), 48913-48922.
184. T. Yamamoto, W. Maruyama, Y. Kato, H. Yi, M. Shamoto-Nagai, M. Tanaka, Y. Sato and M. Naoi, Selective nitration of mitochondrial complex I by peroxynitrite: involvement in mitochondria dysfunction and cell death of dopaminergic SH-SY5Y cells, J Neural Transm 109 (2002), 1-13.
185. Y. Yang, E.J. Mufson and K. Herrup, Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease, J Neurosci 23 (2003), 2557-2563.
186. K.J. Yin, J.M. Lee, S.D. Chen, J. Xu and C.Y. Hsu, Amyloid-beta induces Smac release via AP-1/Bim activation in cerebral endothelial cells, J Neurosci 22 (2002), 9764-9770.
187. J. Yuan and B.A. Yankner, Apoptosis in the nervous system, Nature 407 (2000), 802-809.
188. M. Yuzaki and K. Mikoshiba, Pharmacological and immunocytochemical characterization of metabotropic glutamate receptors in cultured Purkinje cells, J Neurosci 12 (1992), 4253-4263.
189. Y. Zhang, R. McLaughlin, C. Goodyer and A. LeBlanc, Selective cytotoxicity of intracellular amyloid beta peptide 1-42 through p53 and Bax in cultured primary human neurons, J Cell Biol 156 (2002), 519-529.
190. Z. Zhang, H. Hartmann, V.M. Do, D. Abramowski, C. Sturchler-Pierrat, M. Staufenbiel, B. Sommer, M. van de Wetering, H. Clevers, P. Saftig, B. De Strooper, X. He and B.A. Yankner, Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis, Nature 395 (1998), 698-702.
191. Q. Zheng-Fischhofer, J. Biernat, E.M. Mandelkow, S. Illenberger, R. Godemann and E. Mandelkow, Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical- filament-like conformation, Eur J Biochem 252 (1998), 542-552.
192. X. Zhu, A.K. Raina, H.G. Lee, M. Chao, A. Nunomura, M. Tabaton, R.B. Petersen, G. Perry and M.A. Smith, Oxidative Stress and Neuronal Adaptation in Alzheimer Disease: The Role of SAPK Pathways, Antioxid Redox Signal 5 (2003), 571-576.
193. H. Zou, W.J. Henzel, X. Liu, A. Lutschg and X. Wang, Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3, Cell 90 (1997), 405-413.